Moving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
August 29, 2026
Munich
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
August 30, 2026
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
Ryan Quigley
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Exploring Deeper Silencing in Transthyretin Amyloidosis
How Symptoms Shape Caregiver Burden in ATTR-CM
PiB PET Uncovers Hidden ATTR-CM
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Valmiki Maharaj, MD
Closing Diagnostic Gaps in ATTR-CM
Ronald Witteles, MD
Recognizing ATTR-CM in High-Risk Populations
Steve Jackson, PharmD
Frederick Ruberg, MD
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Shelina Ramnarine, PhD
Recognizing and Managing Swelling in ATTR-CM
Kevin S. Shah, MD
Understanding Real-World Testing Patterns in ATTR-CM
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.